IFRXNasdaq

InflaRx N.V.

Pharmaceutical Preparations · P7 · CIK 1708688

InflaRx N.V. develops and commercializes product candidates, facing risks from product liability lawsuits and cybersecurity incidents

$236M

Market cap

$2.24

Last close

-1.8%

+16.1%

1.6M

Volume

Price · last 40 sessions+5.2%

May 4L $1.60 · H $2.74Jun 30

191

Total filings

Jun 30, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance